Lung cancer: open trials in Slovakia

6 open trials have a site in Slovakia. Registry data; only the trial team decides who can take part.

NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · Pfizer
Narodny onkologicky ustav, Bratislava · University Hospital Bratislava, Bratislava · Nemocnica s poliklinikou Stefana Kukuru Michalovce, a.s., Michalovce · Fakultna nemocnica s poliklinikou Nove Zamky, Nové Zámky
Registry updated 2026-11-05
NCT06452277
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 3 · Bayer
POKO Poprad s.r.o., Poprad · Fakultna nemocnica Trnava, Trnava
Registry updated 2026-11-04
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica, Banská Bystrica · Univerzitná nemocnica Bratislava - Nemocnica Ružinov, Bratislava · Vychodoslovensky Onkologicky Ustav a.s., Košice
Registry updated 2026-11-04
NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AbbVie
F D Roosevelt University General Hospital Of Banska Bystrica, Banska Bystrica
Registry updated 2026-10-29
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Trial Treatment · Phase 1/2 · Pfizer
Onkologicky ustav sv. Alzbety, s.r.o., Bratislava · National Oncology Institute, Bratislava · Fakultna nemocnica s poliklinikou Nove Zamky, Nové Zámky · POKO Poprad s.r.o., Poprad
Registry updated 2026-10-28
NCT06758401
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Trial Treatment · Phase 3 · Pfizer
University Hospital Bratislava, Bratislava · Nemocnica AGEL Komarno s.r.o., Komarno · Vychodoslovensky Onkologicky Ustav a.s., Košice · Fakultna nemocnica s poliklinikou Nove Zamky, Nové Zámky · POKO Poprad s.r.o., Poprad · Fakultna nemocnica Trnava, Trnava
Registry updated 2026-09-25

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Lung cancer: open trials in Slovakia

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.